Multimodality molecular imaging of the lung

Delphine L. Chen, Paul E. Kinahan

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Lung diseases cause significant morbidity and mortality and lead to high healthcare utilization. However, few lung disease-specific biomarkers are available to accurately monitor disease activity for the purposes of clinical management or drug development. Advances in cross-modal imaging technologies, such as combined positron emission tomography (PET) and magnetic resonance (MR) imaging scanners and PET or single-photon emission computed tomography (SPECT) combined with computed tomography (CT), may aid in the development of noninvasive, molecular-based biomarkers for lung disease. However, the lungs pose particular challenges in obtaining accurate quantification of imaging data due to the low density of the organ and breathing motion. This review covers the basic physics underlying PET, SPECT, CT, and MR lung imaging and presents technical considerations for multimodal imaging with regard to PET and SPECT quantification. It also includes a brief review of the current and potential clinical applications for these hybrid imaging technologies.

Original languageEnglish
Pages (from-to)391-401
Number of pages11
JournalClinical and Translational Imaging
Issue number5
StatePublished - Oct 25 2014


  • Lung cancer
  • Lung disease
  • Magnetic resonance imaging
  • Molecular imaging
  • Multimodality imaging
  • Positron emission tomography
  • Single photon emission computed tomography


Dive into the research topics of 'Multimodality molecular imaging of the lung'. Together they form a unique fingerprint.

Cite this